Evaluation of amifostine for protection against cisplatin-induced serious hearing loss in children treated for average-risk or high-risk medulloblastoma
Supplementary Data
Supplementary Data
Files in this Data Supplement:
Supplementary Figure 1
- doc file
Supplementary Table 1
- doc file